The AN69 ST haemodialysis membrane under conditions of two different extracorporeal circuit rinse protocols - A comparison of thrombogenicity parameters

Nephrology Dialysis Transplantation

Volumn 22, Issue 10, 2007, Pages 2978-2984

  Richtrova, Pavlina ^a   Opatrny Jr , Karel ^a   Vit, Ladislav ^a   Sefrna, Frantisek ^a   Perlik, Radek ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Biocompatibility; Haemodialysis; Platelet factor 4; Polyacrylonitrile; Thrombin antithrombin complexes; Thrombogenicity

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; HEPARIN; POLYACRYLONITRILE; RECOMBINANT ERYTHROPOIETIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE FACTOR 4;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSSOVER PROCEDURE; DIALYSIS MEMBRANE; DRUG BLOOD LEVEL; DRUG SOLUBILITY; FEMALE; HEMODIALYSIS; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; THROMBOGENICITY;

ACRYLIC RESINS; ADSORPTION; AGED; BIOCOMPATIBLE MATERIALS; BLOOD PLATELETS; CROSS-OVER STUDIES; EQUIPMENT DESIGN; FEMALE; HEMODIALYSIS SOLUTIONS; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET FACTOR 4; PROSPECTIVE STUDIES; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBOSIS; TIME FACTORS;

EID: 36048939745     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm137     Document Type: Article

References (19)

1. Renaux JL, Thomas M, Crost T, Loughraieb N, Vantard G. Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution and pH. Kidney Int 1999; 55: 1097-1103
2. Wright MJ, Woodrow G, Umpleby S, Hull S, Brownjohn AM, Turney JH. Low thrombogenicity of polyethylene glycol-grafted cellulose membranes does not influence heparin requirements in hemodialysis. Am J Kidney Dis 1999; 34: 36-42
3. Hamada Y, Kawachi K, Nakata T, Kohtani T, Takano S, Tsunooka N. Anti-inflammatory effect of heparin-coated circuits with leukocyte-depleting filters in coronary bypass surgery. Artif Organs 2001; 25: 1004-1008
4. Chanard J, Lavaud S, Randoux C, Rieu P. New insights in dialysis membrane biocompatibility: relevance of adsorption properties and heparin binding. Nephrol Dial Transplant 2003; 18: 252-257
5. Colman RW, Schmaier AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive and proinflammatory attributes. Blood 1997; 90: 3819-3843
6. Chanard J, Lavaud S, Paris B et al. Assessment of heparin binding to the AN69 ST hemodialysis membrane: I. Preclinical studies. ASAIO J 2005; 51: 342-347
7. Lavaud S, Canivet E, Wuillai A et al. Optimal anticoagulation strategy in haemodialysis with heparin-coated polyacrylonitrile membrane. Nephrol Dial Transplant 2003; 18: 2097-2104
8. Lavaud S, Paris B, Maheut H et al. Assessment of the heparin-binding AN69 ST hemodialysis membrane: II. Clinical studies without heparin administration. ASAIO J 2005; 51: 348-351
9. Lane DA, Bowry SK. The scientific basis for selection of measures of thrombogenicity. Nephrol Dial Transplant 1994; 9 [Suppl 2]: 18-28
10. Lindhout T. Biocompatibility of extracorporeal blood treatment. Selection of haemostatic parameters. Nephrol Dial Transplant 1994; 9 [Suppl 2]: 83-89
11. Coli L, De Sanctis LB, Feliciangeli G et al. Dialysis membrane biocompatibility: effects on cellular elements. Nephrol Dial Transplant 1995; 10 [Suppl 10]: 27-32
12. Finuzzi G, Remuzzi G. Heparin-induced thrombocytopenia - background and implications for haemodialysis. Nephrol Dial Transplant 1996; 11: 212
13. Massy ZA, Nguyen Khoa T, Lacour B, Descamps-Latscha B, Man NK, Jungers P. Dyslipidaemia and the progression of renal disease in chronic renal failure patients. Nephrol Dial Transplant 1999; 14: 2392-2397
14. Leitienne P, Fouque D, Rigal D, Adeleine P, Trzeciak MC, Laville M. Heparins and blood polymorphonuclear stimulation in haemodialysis: an expansion of the biocompatibility concept. Nephrol Dial Transplant 2000; 15: 1631-1637
15. Zemanova P, Opatrny K,Jr, Vit L, Sefrna F. Tissue factor, its inhibitor and the thrombogenicity of two new synthetic membranes. Artif Organs 2005; 29: 651-657
16. Gurland HJ, Davison AM, Bonomini V et al. Definitions and terminology in biocompatibility. Nephrol Dial Transplant 1994; 9 [Suppl 2]: 4-10
17. Cianciolo G, Stefoni S, Donati G et al. Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes. Nephrol Dial Transplant 2001; 16: 1222-1229
18. De Sanctis LB, Stefoni S, Cianciolo G et al. Effect of different dialysis membranes on platelet function. A tool for biocompatibility evaluation. Int J Artif Organs 1996; 19: 404-410
19. Itoh S, Susuki C, Tsuji T. Platelet activation through interaction with hemodialysis membranes induces neutrophils to produce reactive oxygen species. J Biomed Mater Res A 2006; 77: 294-303